Understanding how TDP-43 affects RNA transport in neurons and its role in ALS
Mechanistic analysis of TDP-43-mediated RNA localization in neurons and its misregulation in ALS
This study is looking at how a protein called TDP-43 affects the movement of RNA in nerve cells, which is important for keeping those cells healthy, and it's aimed at helping people with ALS by finding out more about what goes wrong in their bodies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10931416 on NIH RePORTER |
What this research studies
This research investigates the role of the TDP-43 protein in the localization of RNA within neurons, which is crucial for proper neuronal function. By examining how TDP-43 mutations contribute to the misregulation of RNA transport, the study aims to uncover the underlying mechanisms of Amyotrophic Lateral Sclerosis (ALS). The researchers will utilize advanced techniques such as subcellular transcriptomics and live cell microscopy to monitor RNA localization in neurons. This approach could lead to new insights into ALS pathology and potential therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Amyotrophic Lateral Sclerosis or related neurodegenerative conditions.
Not a fit: Patients with neurological conditions unrelated to ALS or those without any neurodegenerative diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatment options for patients with ALS by targeting the mechanisms of RNA mislocalization.
How similar studies have performed: Previous research has shown promising results in understanding RNA localization in other neurological diseases, suggesting that this approach may yield valuable insights for ALS as well.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Taliaferro, Jefferson Matthew — University of Colorado Denver
- Study coordinator: Taliaferro, Jefferson Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.